Skip to main content

Aridis Pharmaceuticals, Inc.

ARDSDelisted Sep 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001614067

Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.

13F holders, Q1 2021

Institutional positions in Aridis Pharmaceuticals, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
12
No complete 13F data for Q4 2020
Shares held
1.01M
No complete 13F data for Q4 2020
Total value
$5.97M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting ARDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 12 institutions
Q1 2021: 12 institutionsQ2 2021: 13 institutionsQ3 2021: 18 institutionsQ4 2021: 20 institutionsQ1 2022: 22 institutionsQ2 2022: 19 institutionsQ3 2022: 16 institutionsQ4 2022: 17 institutionsQ1 2023: 20 institutionsQ2 2023: 18 institutionsQ3 2023: 1 institutionQ4 2023: 2 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 1 institutionQ4 2025: 0 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2021: $5.97M
Q1 2021: $5.97MQ2 2021: $7.87MQ3 2021: $7.33MQ4 2021: $2.96MQ1 2022: $3.38MQ2 2022: $2.05MQ3 2022: $1.79MQ4 2022: $4.58MQ1 2023: $1.29MQ2 2023: $392.3KQ3 2023: $1.44KQ4 2023: $10Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $3Q4 2025: $0Q1 2026: $1Q2 2026: $0
Institutions holding ARDS and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$1
Q4 20250$0
Q3 20251$3
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20232$10
Q3 20231$1.44K
Q2 202318$392.3K
Q1 202320$1.29M
Q4 202217$4.58M
Q3 202216$1.79M
Q2 202219$2.05M
Q1 202222$3.38M
Q4 202120$2.96M
Q3 202118$7.33M
Q2 202113$7.87M
Q1 202112$5.97M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Aridis Pharmaceuticals, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding ARDS in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
AIGH Capital Management LLC423,357$2.50M0.86%––
Roumell Asset Management, LLC222,222$1.31M1.90%––
Vanguard Group Inc149,658$883.0K0.00%––
Worth Venture Partners, LLC105,413$622.0K0.30%––
Minot Wealth Management LLC72,230$426.0K0.11%––
BlackRock Inc.26,381$156.0K0.00%––
Perritt Capital Management Inc10,100$60.0K0.03%––
Wells Fargo & Company1,266$7.00K0.00%––
Citigroup Inc750$4.00K0.00%––
Morgan Stanley500$3.00K0.00%––
Financial Perspectives, Inc1,475$2500.01%––
Bank of America Corp28$00.00%––